Search research articles
Contact Us
Filters
Showing results (201-210 of 215) with videos related to
Page
of 22
Sort By:
Journal of Viral Hepatitis
|
June 16, 2015
Effectiveness of triple therapy with simeprevir for chronic hepatitis C genotype 1b patients with prior telaprevir failure
E Ogawa, N Furusyo, K Dohmen, et al.
Die Pharmazie
|
January 8, 2020
Nutritional factors affecting length of hospital stay in patients undergoing cardiovascular surgery
M Yasuda, T Tachi, M Fukuta, et al.
Alimentary Pharmacology & Therapeutics
|
October 9, 2013
Telaprevir-based triple therapy for chronic hepatitis C patients with advanced fibrosis: a prospective clinical study
E Ogawa, N Furusyo, M Nakamuta, et al.
Hepato-Gastroenterology
|
July 31, 1998
Studies of postoperative transarterial infusion chemotherapy for liver metastasis of colorectal carcinoma after hepatectomy
T Asahara, M Kikkawa, M Okajima, et al.
Alimentary Pharmacology & Therapeutics
|
October 17, 2017
Short-term risk of hepatocellular carcinoma after hepatitis C virus eradication following direct-acting anti-viral treatment
E Ogawa, N Furusyo, H Nomura, et al.
Hiroshima Journal of Medical Sciences
|
December 22, 1999
Brain metastasis from hepatocellular carcinoma after radical hepatectomy
T Asahara, M Yano, S Fukuda, et al.
Hiroshima Journal of Medical Sciences
|
November 12, 1998
Factors affecting postoperative prognosis in the solitary-nodule type of hepatocellular carcinoma: experience of 132 cases in our institute
T Asahara, K Dohi, K Katayama, et al.
Veterinary and Comparative Oncology
|
January 15, 2016
Photodynamic detection of canine mammary gland tumours after oral administration of 5-aminolevulinic acid
T Osaki, I Yokoe, S Ogura, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 9, 2017
Monitoring of somatic mutations in circulating cell-free DNA by digital PCR and next-generation sequencing during afatinib treatment in patients with lung adenocarcinoma positive for EGFR activating mutations
E Iwama, K Sakai, K Azuma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2015
A randomized, double-blind, placebo-controlled, phase III trial of erlotinib with or without a c-Met inhibitor tivantinib (ARQ 197) in Asian patients with previously treated stage IIIB/IV nonsquamous nonsmall-cell lung cancer harboring wild-type epidermal growth factor receptor (ATTENTION study)
H Yoshioka, K Azuma, N Yamamoto, et al.
Page
of 22
Search research articles
Search
Showing results (201-210 of 215) with videos related to
Sort By:
Page
of 22
Journal of Viral Hepatitis
|
June 16, 2015
Effectiveness of triple therapy with simeprevir for chronic hepatitis C genotype 1b patients with prior telaprevir failure
E Ogawa, N Furusyo, K Dohmen, et al.
Die Pharmazie
|
January 8, 2020
Nutritional factors affecting length of hospital stay in patients undergoing cardiovascular surgery
M Yasuda, T Tachi, M Fukuta, et al.
Alimentary Pharmacology & Therapeutics
|
October 9, 2013
Telaprevir-based triple therapy for chronic hepatitis C patients with advanced fibrosis: a prospective clinical study
E Ogawa, N Furusyo, M Nakamuta, et al.
Hepato-Gastroenterology
|
July 31, 1998
Studies of postoperative transarterial infusion chemotherapy for liver metastasis of colorectal carcinoma after hepatectomy
T Asahara, M Kikkawa, M Okajima, et al.
Alimentary Pharmacology & Therapeutics
|
October 17, 2017
Short-term risk of hepatocellular carcinoma after hepatitis C virus eradication following direct-acting anti-viral treatment
E Ogawa, N Furusyo, H Nomura, et al.
Hiroshima Journal of Medical Sciences
|
December 22, 1999
Brain metastasis from hepatocellular carcinoma after radical hepatectomy
T Asahara, M Yano, S Fukuda, et al.
Hiroshima Journal of Medical Sciences
|
November 12, 1998
Factors affecting postoperative prognosis in the solitary-nodule type of hepatocellular carcinoma: experience of 132 cases in our institute
T Asahara, K Dohi, K Katayama, et al.
Veterinary and Comparative Oncology
|
January 15, 2016
Photodynamic detection of canine mammary gland tumours after oral administration of 5-aminolevulinic acid
T Osaki, I Yokoe, S Ogura, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 9, 2017
Monitoring of somatic mutations in circulating cell-free DNA by digital PCR and next-generation sequencing during afatinib treatment in patients with lung adenocarcinoma positive for EGFR activating mutations
E Iwama, K Sakai, K Azuma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2015
A randomized, double-blind, placebo-controlled, phase III trial of erlotinib with or without a c-Met inhibitor tivantinib (ARQ 197) in Asian patients with previously treated stage IIIB/IV nonsquamous nonsmall-cell lung cancer harboring wild-type epidermal growth factor receptor (ATTENTION study)
H Yoshioka, K Azuma, N Yamamoto, et al.
Page
of 22